Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4546 to 4560 of 7691 results

  1. Risk of radiotherapy in people with cancer and COVID-19: Are patients with cancer and COVID-19 who are receiving/have recently received radiotherapy (that is, within the 4 weeks preceding a diagnosis of COVID-19) at increased risk of severe COVID-19 illness or death?

    Recommendation ID NG162/1 Question Risk of radiotherapy in people with cancer and COVID-19: Are patients with cancer and COVID-19 who are

    Research recommendation
    Published
    21 October 2021

  2. Risk of systemic anticancer treatment in people with cancer and COVID-19: Are patients with cancer and COVID-19 who are receiving/have recently received systemic anticancer treatment (SACT) (that is, within the 4 weeks preceding a diagnosis of COVID-19) at increased risk of severe COVID-19 illness or death?

    Recommendation ID NG161/1 Question Risk of systemic anticancer treatment in people with cancer and COVID-19: Are patients with cancer and

    Research recommendation
    Published
    21 October 2021

  3. Clinical trials should be conducted comparing ticagrelor with prasugrel in people with acute coronary syndromes (ACS).

    Recommendation ID TA236/1 Question Clinical trials should be conducted comparing ticagrelor with prasugrel in people with acute coronary

    Research recommendation
    Published
    9 June 2015

  4. Clinicians are encouraged to collect long-term data on clinical outcomes and patient-reported quality-of-life outcomes using validated scales. NICE may update the guidance on publication of further evidence.

    Recommendation ID IPG581/1 Question Clinicians are encouraged to collect long-term data on clinical outcomes and patient-reported quality-of-life

    Research recommendation
    Published
    12 October 2018

  5. Clinicians should enter details about all patients having selective internal radiation therapy (SIRT) for unresectable primary intrahepatic cholangiocarcinoma onto a suitable registry.

    Recommendation ID IPG630/2 Question Clinicians should enter details about all patients having selective internal radiation therapy (SIRT)

    Research recommendation
    Published
    18 December 2018

  6. Clinicians are encouraged to collect long-term data on clinical outcomes and patient-reported quality-of-life outcomes using validated scales. NICE may update the guidance on publication of further evidence into infracoccygeal sacropexy using mesh to repair uterine prolapse.

    Recommendation ID IPG582/1 Question Clinicians are encouraged to collect long-term data on clinical outcomes and patient-reported quality-of-life

    Research recommendation
    Published
    12 October 2018

  7. Which patient groups, contamination groups and which layers gain the most benefit from the use of triclosan-coated or triclosan-impregnated sutures?

    Recommendation ID NG125/5 Question Which patient groups, contamination groups and which layers gain the most benefit from the use of triclosan-coated

    Research recommendation
    Published
    16 August 2019

  8. Clinicians should collect data on all patients undergoing focal cryoablation (including details of case selection, methods of follow-up and outcomes) for local audit. Clinicians should enter details about all patients undergoing focal therapy using cryoablation for localised prostate cancer onto the European Registry for Cryosurgical Ablation of the Prostate (EuCAP) register and review clinical outcomes locally.

    Recommendation ID IPG423/2 Question Clinicians should collect data on all patients undergoing focal cryoablation (including details of

    Research recommendation
    Published
    9 June 2015

  9. What is the impact of coexisting physical health conditions on the mortality of people with complex psychosis?

    Recommendation ID NG181/8 Question What is the impact of coexisting physical health conditions on the mortality of people with complex

    Research recommendation
    Published
    26 October 2020

  10. Cognitive assessment:- What is the impact of assessing for cognitive and behaviour change in people with motor neurone disease (MND) on clinical practice, the person and their family and carers? Does repeated assessment provide more benefit than assessment at a single point at diagnosis?

    Recommendation ID NG42/2 Question Cognitive assessment:- What is the impact of assessing for cognitive and behaviour change in people with

    Research recommendation
    Published
    21 March 2016

  11. What is the clinical and cost effectiveness of fitting amplification devices(s) in people with tinnitus who have hearing loss but no perceived hearing difficulties?

    Recommendation ID NG155/12 Question What is the clinical and cost effectiveness of fitting amplification devices(s) in people with tinnitus

    Research recommendation
    Published
    17 March 2020

  12. What is the optimal method for assessing tinnitus in general practice (including consultation questions, physical examinations and questionnaires)?

    Recommendation ID NG155/3 Question What is the optimal method for assessing tinnitus in general practice (including consultation questions

    Research recommendation
    Published
    17 March 2020

  13. What is the clinical and cost effectiveness of a combination management strategy consisting of sound therapy and tinnitus support?

    Recommendation ID NG155/2 Question What is the clinical and cost effectiveness of a combination management strategy consisting of sound

    Research recommendation
    Published
    17 March 2020

  14. What is the clinical and cost effectiveness of a combination management strategy consisting of sound therapy and tinnitus support?

    Recommendation ID NG155/2 Question What is the clinical and cost effectiveness of a combination management strategy consisting of sound

    Research recommendation
    Published
    17 March 2020

  15. What is the clinical and cost effectiveness of cognitive behavioural therapy (CBT) for adults with tinnitus delivered by appropriately trained healthcare professionals other than psychologists (for example, audiologists)?

    Recommendation ID NG155/1 Question What is the clinical and cost effectiveness of cognitive behavioural therapy (CBT) for adults with tinnitus

    Research recommendation
    Published
    17 March 2020